The US Food and Drug Administration on Tuesday approved Ozempic for adults with type 2 diabetes and chronic kidney disease (CKD). The drug is now indicated specifically to treat kidney failure, ...
OpenAI was openly challenged by Chinese startup DeepSeek in the AI arena, which the ChatGPT maker has commanded since 2022.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback